The Macular Automated Phototre Tet Original Reearch Article

Purpoe To introduce a tandardized macular phototre tet uing an automated perimeter a a method to quantify macular dieae everity and a a tool to ditinguih optic neuropathy from macular pathology. Deign Propective interventional pilot tudy. Method Twenty-five bilaterally peudophakic ubject aged range, 65 to 84: 15 patient with varying everity of non-neovacular age-related macular degeneration (AMD), five patient with no ocular dieae, and five patient with moderate primary open-angle glaucoma (POAG). Previouly reported normative value erved a control for thi tudy. Patient underwent foveal threhold teting uing the Humphrey Viual Field Perimeter Model 750 (Carl Zei Meditec, Inc, Dublin, California, UA). Baeline meaurement were compared to threhold enitivity after phototre at one minute and then two-minute interval until enitivity returned to baeline. Main outcome meaure were baeline foveal threhold enitivity, foveal threhold depreion, and recovery following phototre. Reult Automated macular phototre teting in macular dieae (AMD) caue a decreae (P < .001) in baeline foveal enitivity and a delay (P < .001) in recovery time to baeline enitivity. Optic nerve pathology (POAG) doe not affect (P = .343) the foveal repone curve. Concluion The macular automated phototre (MAP) tet i an inexpenive, noninvaive, and readily acceible adjunct for evaluating patient with macular dieae. Thi tandardized protocol i ueful in objectively defining dieae everity, may be ued to follow repone to treatment, and could aid in ditinguihing optic neuropathy from macular pathology.